pharmathen

Private

—N/Ahttps://pharmathen.com

Last Round

Buyout/LBO

7/19/2021

Last Round Size

$1.9B

Est. Valuation

$1.9B

Total Funding Raised

$2.4B

Company Overview

Developer and manufacturer of complex generic pharmaceutical products and advanced drug delivery technologies.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

pharmathen Comps

Related companies by embedding similarity.

Company	Similarity	Domain
SpaceX	0%	—
Tesla	0%	—
Competitor 1	XX%	—
Competitor 2	XX%	—

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

pharmathen Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Buyout/LBO	7/19/2021
Buyout/LBO	6/3/2015

View all Funding Rounds

pharmathen Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

pharmathen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about pharmathen's valuation, stock price, and market status.

Firmographic Details

Headquarters—

Year Founded1969

Last Funding7/19/2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

Login

Use CasesInvestors Employees

CompaniesAll Companies

LegalPrivacy Policy Terms of Use BrokerCheck Form CRS

DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.